Notícias e Atividades da United Therapeutics

United Therapeutics é uma das ...

• Forbes Global 2000 (#1538);
• Russell 3000;
• TOB Iconic 10,000.

United Therapeutics é uma empresa listada sob o símbolo UTHR (US).

Veja o organograma con seus 31 executivos principais

Biografias mais buscadas da United Therapeutics

• Martine Rothblatt, Chairman of the Board and Chief Executive Offic...
• Judy Olian, Director
• Louis Sullivan, Director

Criar um alerta
para seguir os movimentos de executivos da United Therapeutics.

United Therapeutics possui 2.347 concorrentes concorrentes Eurofins (Luxemburgo), Lonza (Suíça) e Johnson & Johnson Innovative Medicine DIA (Estados Unidos).

Popular M&A news in Biotecnologia

• Attovia Therapeutics acaba de anunciar uma arrecadação de fundos de 90 milhões de dólares. (publicado em 21 de abril de 2025).
• Transcarent and Accolade have merged  (publicado em 9 de abril de 2025)..
• Kashiv BioSciences acaba de anunciar uma arrecadação de fundos de 150 milhões de dólares. (publicado em 7 de abril de 2025).

Outros contatos sugeridos na indústria do Biotecnologia

• Kristina Burow - Director da Scholar Rock
• Steven Gillis - Chairman of the Board da VBI Vaccines
• Ali Behbahani - Non-Executive Director da Adaptimmune Therapeutics

Saiba mais sobre a indústria do Biotecnologia

Últimos comunicados de imprensa de United Therapeutics

• United Therapeutics Corporation to Report First Quarter 2025 Financial Results Before Market Open on Wednesday, April 30, 2025
• United Therapeutics Named to ‘100 Best Companies to Work For’ in 2025 by Fortune Media and Great Place to Work
• United Therapeutics Corporation to Feature Clinical Data Across its Commercial and Development Portfolio at the International Society for Heart and Lung Transplantation 45th Annual Meeting and Scientific Sessions
• United Therapeutics Corporation to Present at the Leerink Partners Global Healthcare Conference 2025
• United Therapeutics Corporation to Report Fourth Quarter and Full Year 2024 Financial Results Before the Market Opens on Wednesday, February 26, 2025
• United Therapeutics Corporation Announces FDA Clearance of its Investigational New Drug Application for the UKidney Xenotransplantation Clinical Trial
• United Therapeutics Corporation Announces Full Enrollment of the TETON 1 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis
• United Therapeutics Corporation to Feature Clinical Data Across its Commercial and Development Portfolio at the Pulmonary Vascular Research Institute 2025 Annual Congress
• United Therapeutics Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference
• United Therapeutics Announces Successful World’s First UKidney Transplant
• View more press releases Close

Redes sociais sobre United Therapeutics

• United Therapeutics na Wikipedia, Google News e Yahoo Finance
• United Therapeutics na LinkedIn, Twitter e YouTube